XML 27 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Financial Instruments
3 Months Ended
Apr. 01, 2018
Financial Instruments

F. FINANCIAL INSTRUMENTS

Cash Equivalents

Teradyne considers all highly liquid investments with maturities of three months or less at the date of acquisition to be cash equivalents.

Marketable Securities

Effective January 1, 2018, Teradyne adopted ASU 2016-01,Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities” using the modified retrospective approach. This guidance requires that changes in fair value of equity securities be accounted for directly in earnings. Prior to 2018, the changes in fair value of equity securities were recorded in accumulated other comprehensive income on the balance sheet.

 

On a quarterly basis, Teradyne reviews its investments to identify and evaluate those that have an indication of a potential other-than-temporary impairment. Factors considered in determining whether a loss is other-than-temporary include:

 

    The length of time and the extent to which the market value has been less than cost;

 

    The financial condition and near-term prospects of the issuer; and

 

    The intent and ability to retain the investment in the issuer for a period of time sufficient to allow for any anticipated recovery in market value.

Teradyne uses the market and income approach techniques to value its financial instruments and there were no changes in valuation techniques during the three months ended April 1, 2018 and April 2, 2017. As defined in ASC 820-10,Fair Value Measurements and Disclosures,” fair value is the price that would be received from the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. ASC 820-10 requires that assets and liabilities carried at fair value be classified and disclosed in one of the following three categories:

Level 1: Quoted prices in active markets for identical assets as of the reporting date;

Level 2: Inputs other than Level 1, that are observable either directly or indirectly as of the reporting date. For example, a common approach for valuing fixed income securities is the use of matrix pricing. Matrix pricing is a mathematical technique used to value securities by relying on the securities’ relationship to other benchmark quoted prices, and is considered a Level 2 input; or

Level 3: Unobservable inputs that are not supported by market data. Unobservable inputs are developed based on the best information available, which might include Teradyne’s own data.

Teradyne’s available-for-sale debt securities are classified as Level 2, and equity securities are classified as Level 1. Acquisition-related contingent consideration is classified as Level 3. Teradyne determines the fair value of acquisition-related contingent consideration using a Monte Carlo simulation model. Assumptions utilized in the model include forecasted revenues, revenue volatility and discount rate. The vast majority of Level 2 securities are fixed income securities priced by third party pricing vendors. These pricing vendors utilize the most recent observable market information in pricing these securities or, if specific prices are not available, use other observable inputs like market transactions involving identical or comparable securities.

Realized gains recorded in the three months ended April 1, 2018 and April 2, 2017 were $0.3 million and $0.3 million, respectively. Realized losses recorded in the three months ended April 1, 2018 and April 2, 2017 were $1.5 million and $0.2 million, respectively. Realized gains are included in interest income and realized losses are included in interest expense.

Unrealized gains and losses on available-for-sale debt securities are included in accumulated other comprehensive income (loss). Changes in fair value of equity securities are included in other (income) expense, net. The cost of securities sold is based on the specific identification method.

During the three months ended April 1, 2018 and April 2, 2017, there were no transfers in or out of Level 1, Level 2 or Level 3 financial instruments.

 

The following table sets forth by fair value hierarchy Teradyne’s financial assets and liabilities that were measured at fair value on a recurring basis as of April 1, 2018 and December 31, 2017.

 

     April 1, 2018  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 155,543      $ —        $ —        $ 155,543  

Cash equivalents

     306,710        175,620        —          482,330  

Available-for-sale debt securities:

           

U.S. Treasury securities

     —          611,946        —          611,946  

Commercial paper

     —          252,158        —          252,158  

Corporate debt securities

     —          44,218        —          44,218  

U.S. government agency securities

     —          10,726        —          10,726  

Certificates of deposit and time deposits

     —          4,824        —          4,824  

Debt mutual funds

     2,741        —          —          2,741  

Non-U.S. government securities

     —          559        —          559  

Equity securities:

           

Mutual funds

     22,613        —          —          22,613  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 487,607      $ 1,100,051      $ —        $ 1,587,658  

Derivative assets

     —          12        —          12  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 487,607      $ 1,100,063      $ —        $ 1,587,670  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —        $ —        $ 15,581      $ 15,581  

Derivative liabilities

     —          224        —          224  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ 224      $ 15,581      $ 15,805  
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 462,253      $ 175,620      $ —        $ 637,873  

Marketable securities

     —          860,526        —          860,526  

Long-term marketable securities

     25,354        63,905        —          89,259  

Prepayments

     —          12        —          12  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 487,607      $ 1,100,063      $ —        $ 1,587,670  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

     .           

Other current liabilities

   $ —        $ 224      $ —        $ 224  

Contingent consideration

     —          —          15,581        15,581  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ 224      $ 15,581      $ 15,805  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

     December 31, 2017  
     Quoted Prices
in Active
Markets for
Identical
Instruments
(Level 1)
     Significant
Other
Observable
Inputs
(Level 2)
     Significant
Unobservable
Inputs
(Level 3)
     Total  
     (in thousands)  

Assets

           

Cash

   $ 197,955      $ —        $ —        $ 197,955  

Cash equivalents

     206,335        25,553        —          231,888  

Available-for-sale securities:

           

U.S. Treasury securities

     —          855,795        —          855,795  

Commercial paper

     —          282,840        —          282,840  

Certificates of deposit and time deposits

     —          167,342        —          167,342  

Corporate debt securities

     —          133,186        —          133,186  

Equity and debt mutual funds

     23,430        —          —          23,430  

U.S. government agency securities

     —          10,726        —          10,726  

Non-U.S. government securities

     —          586        —          586  
  

 

 

    

 

 

    

 

 

    

 

 

 
   $ 427,720      $ 1,476,028      $ —        $ 1,903,748  

Derivative assets

     —          389        —          389  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 427,720      $ 1,476,417      $ —        $ 1,904,137  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Contingent consideration

   $ —        $ —        $ 45,102      $ 45,102  

Derivative liabilities

     —          446        —          446  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ 446      $ 45,102      $ 45,548  
  

 

 

    

 

 

    

 

 

    

 

 

 

Reported as follows:

 

     (Level 1)      (Level 2)      (Level 3)      Total  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 404,290      $ 25,553      $ —        $ 429,843  

Marketable securities

     —          1,347,979        —          1,347,979  

Long-term marketable securities

     23,430        102,496        —          125,926  

Prepayments

     —          389        —          389  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 427,720      $ 1,476,417      $ —        $ 1,904,137  
  

 

 

    

 

 

    

 

 

    

 

 

 

Liabilities

           

Other accrued liabilities

   $ —        $ 446      $ —        $ 446  

Contingent consideration

     —          —          24,497        24,497  

Long-term contingent consideration

     —          —          20,605        20,605  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ —        $ 446      $ 45,102      $ 45,548  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

Changes in the fair value of Level 3 contingent consideration for the three months ended April 1, 2018 and April 2, 2017 were as follows:

 

     For the Three Months
Ended
 
     April 1,
2018
     April 2,
2017
 
     (in thousands)  

Balance at beginning of period

   $ 45,102      $ 38,332  

Payments (a)

     (24,553      (1,050

Fair value adjustment (b)

     (4,968      634  
  

 

 

    

 

 

 

Balance at end of period

   $ 15,581      $ 37,916  
  

 

 

    

 

 

 

 

(a) In the three months ended April 1, 2018, Teradyne paid $24.6 million of contingent consideration for the earn-out in connection with the acquisition of Universal Robots A/S (“Universal Robots”). In the three months ended April 2, 2017, Teradyne paid $1.1 million of contingent consideration for the earn-out in connection with the acquisition of Avionics Interface Technology, LLC (“AIT”).
(b) In the three months ended April 1, 2018, the fair value of contingent consideration for the earn-out in connection with the acquisition of Universal Robots was decreased by $5.0 million, primarily due to a decrease in forecasted revenue. In the three months ended April 2, 2017, the fair value of contingent consideration for the earn-out in connection with the acquisition of Universal Robots was increased by $0.6 million primarily due to an increase in forecasted revenue and a decrease in the discount rate.

The following table provides quantitative information associated with the fair value measurement of Teradyne’s Level 3 financial instruments:

 

Liability

   April 1, 2018
Fair Value
     Valuation
Technique
     Unobservable Inputs    Weighted
Average
 
     (in thousands)                     

Contingent consideration

(Universal Robots)

   $ 15,581       

Monte Carlo

Simulation

 

 

   Revenue for the period July 1,
    2015—December 31, 2018 volatility
     13.0
         Discount Rate      3.8

As of April 1, 2018, the significant unobservable inputs used in the Monte Carlo simulation to fair value the Universal Robots contingent consideration include forecasted revenue, revenue volatility and discount rate. Increases or decreases in the inputs would result in a higher or lower fair value measurement. The maximum payment for the remaining Universal Robots revenue earn-out is $25.0 million.

The carrying amounts and fair values of Teradyne’s financial instruments at April 1, 2018 and December 31, 2017 were as follows:

 

     April 1, 2018      December 31, 2017  
     Carrying Value      Fair Value      Carrying Value      Fair Value  
     (in thousands)  

Assets

           

Cash and cash equivalents

   $ 637,873      $ 637,873      $ 429,843      $ 429,843  

Marketable securities

     949,785        949,785        1,473,905        1,473,905  

Derivative assets

     12        12        389        389  

Liabilities

           

Contingent consideration

     15,581        15,581        45,102        45,102  

Derivative liabilities

     224        224        446        446  

Convertible debt (1)

     369,421        700,626        365,987        659,525  

 

(1) The carrying value represents the bifurcated debt component only, while the fair value is based on quoted market prices for the convertible note which includes the equity conversion features.

 

The fair values of accounts receivable, net and accounts payable approximate the carrying value due to the short-term nature of these instruments.

The following table summarize the composition of available-for-sale marketable securities at April 1, 2018:

 

     April 1, 2018  
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair
Market

Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

U.S. Treasury securities

   $ 614,365      $ 19      $ (2,438   $ 611,946      $ 610,938  

Commercial paper

     252,579        17        (438     252,158        249,871  

Corporate debt securities

     43,472        1,200        (454     44,218        17,742  

U.S. government agency securities

     10,791        —          (65     10,726        10,726  

Certificates of deposit and time deposits

     4,820        4        —         4,824        —    

Debt mutual funds

     2,799        —          (58     2,741        1,679  

Non-U.S. government securities

     559        —          —         559        —    
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 929,385      $ 1,240      $ (3,453   $ 927,172      $ 890,956  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair
Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 861,794      $ 54      $ (1,322   $ 860,526      $ 847,446  

Long-term marketable securities

     67,591        1,186        (2,131     66,646        43,510  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 929,385      $ 1,240      $ (3,453   $ 927,172      $ 890,956  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

The following table summarize the composition of available-for-sale marketable securities at December 31, 2017:

 

     December 31, 2017  
     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair
Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

U.S. Treasury securities

   $ 858,258      $ 72      $ (2,535   $ 855,795      $ 850,163  

Commercial paper

     283,009        18        (187     282,840        258,933  

Certificates of deposit and time deposits

     167,523        6        (187     167,342        138,340  

Corporate debt securities

     131,179        2,380        (373     133,186        91,010  

Equity and debt mutual funds

     19,403        4,102        (75     23,430        1,723  

U.S. government agency securities

     10,775        —          (49     10,726        10,726  

Non-U.S. government securities

     582        4        —         586        —    
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 1,470,729      $ 6,582      $ (3,406   $ 1,473,905      $ 1,350,896  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

 

Reported as follows:

 

     Cost      Unrealized
Gain
     Unrealized
(Loss)
    Fair
Market
Value
     Fair Market
Value of
Investments
with Unrealized
Losses
 
     (in thousands)  

Marketable securities

   $ 1,349,970      $ 38      $ (2,029   $ 1,347,979      $ 1,288,844  

Long-term marketable securities

     120,759        6,544        (1,377     125,926        62,052  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 
   $ 1,470,729      $ 6,582      $ (3,406   $ 1,473,905      $ 1,350,896  
  

 

 

    

 

 

    

 

 

   

 

 

    

 

 

 

As of April 1, 2018, the fair market value of investments in debt securities with unrealized losses totaled $891.0 million. Of this value, $62.1 million had unrealized losses of $1.6 million for greater than one year and $828.9 million had unrealized losses of $1.9 million for less than one year.

As of December 31, 2017, the fair market value of investments with unrealized losses totaled $1,350.9 million. Of this value, $141.0 million had unrealized losses of $1.2 million for greater than one year and $1,209.9 million had unrealized losses of $2.2 million for less than one year.

Teradyne reviews its investments to identify and evaluate investments that have an indication of possible impairment. Based on this review, Teradyne determined that the unrealized losses related to these investments at April 1, 2018 and December 31, 2017 were temporary.

The contractual maturities of investments in debt securities held at April 1, 2018 were as follows:

 

     April 1, 2018  
     Cost      Fair Market
Value
 
     (in thousands)  

Due within one year

   $ 861,794      $ 860,526  

Due after 1 year through 5 years

     10,173        10,058  

Due after 5 years through 10 years

     14,583        13,823  

Due after 10 years

     40,036        40,024  
  

 

 

    

 

 

 

Total

   $ 926,586      $ 924,431  
  

 

 

    

 

 

 

Contractual maturities of investments in debt securities held at April 1, 2018 exclude $2.7 million of debt mutual funds as they do not have a contractual maturity date.

Derivatives

Teradyne conducts business in a number of foreign countries, with certain transactions denominated in local currencies. The purpose of Teradyne’s foreign currency management is to minimize the effect of exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities. Teradyne does not use derivative financial instruments for trading or speculative purposes.

To minimize the effect of exchange rate fluctuations associated with the remeasurement of monetary assets and liabilities denominated in foreign currencies, Teradyne enters into foreign currency forward contracts. The change in fair value of these derivatives is recorded directly in earnings, and is used to offset the change in value of monetary assets and liabilities denominated in foreign currencies.

The notional amount of foreign currency forward contracts at April 1, 2018 and December 31, 2017 was $108.8 million and $116.8 million, respectively.

Gains and losses on foreign currency forward contracts and foreign currency remeasurement gains and losses on monetary assets and liabilities are included in other (income) expense, net.

 

The following table summarizes the fair value of derivative instruments as of April 1, 2018 and December 31, 2017:

 

     Balance Sheet
Location
     April 1,
2018
    December 31,
2017
 
            (in thousands)  

Derivatives not designated as hedging instruments:

       

Foreign currency forward contracts assets

     Prepayments      $ 12     $ 389  

Foreign currency forward contracts liabilities

     Other current liabilities        (224     (446
     

 

 

   

 

 

 

Total derivatives

      $ (212   $ (57
     

 

 

   

 

 

 

The following table summarizes the effect of derivative instruments recognized in the statement of operations for the three months ended April 1, 2018 and April 2, 2017.

 

   

Location of Losses

Recognized in

Statement of Operations

  For the Three Months
Ended
 
      April 1,
2018
    April 2,
2017
 
       
        (in thousands)  

Derivatives not designated as hedging instruments:

     

Foreign currency forward contracts

  Other (income) expense, net   $ 1,575     $ 1,011  

 

(1) The table does not reflect the corresponding gains and losses from the remeasurement of monetary assets and liabilities denominated in foreign currencies.
(2) For the three months ended April 1, 2018 and April 2, 2017, net gains from the remeasurement of monetary assets and liabilities denominated in foreign currencies were $0.6 million and $1.5 million, respectively.

See Note G: “Debt” regarding derivatives related to the convertible senior notes.